Showing results (791-800 of 3,150) with videos related to

Sort By:
Pageof 315
Neuro-Oncology|August 14, 2026
PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative studyKatharina J Schmidbauer, Isabelle von Polenz, Jonas Reis, et al.
Neuro-Oncology|August 19, 2026
Abexinostat attenuates temozolomide-resistant glioma stem cellsBalaji Perumalsamy, Raghupathy Vengoji, Anand Thiraviyam, et al.
Neuro-Oncology|August 20, 2026
ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumoursLieselotte Lauwens, Catharina M L Zegers, Alida A Postma, et al.
Neuro-Oncology|April 18, 2001
Adult medulloblastoma: multiagent chemotherapyH S Greenberg, M C Chamberlain, M J Glantz, et al.
Neuro-Oncology|April 17, 2001
Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiationH K Shu, C M Julin, F Furman, et al.
Neuro-Oncology|April 17, 2001
Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in childrenV A Levin, K Lamborn, W Wara, et al.
Neuro-Oncology|April 17, 2001
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium studyS C Schold, J G Kuhn, S M Chang, et al.
Neuro-Oncology|April 17, 2001
SETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytesO Bögler, F B Furnari, A Kindler-Roehrborn, et al.
Neuro-Oncology|April 17, 2001
Recurrent astrocytoma in a child: a report of cytogenetics and TP53 gene mutation screeningA Dam, J M Fock, V M Hayes, et al.
Neuro-Oncology|April 17, 2001
Lack of association of rare alleles in the HRAS variable number of tandem repeats (VNTR) region with adult gliomaP Chen, J K Wiencke, K Conway, et al.
Pageof 315